FDA Approves Regeneron Multiple Myeloma Drug With Dosing Edge Over J&J and Pfizer Meds
Regeneron Pharmaceuticals is expanding its cancer drug lineup with FDA approval of a bispecific antibody it developed for multiple myeloma, ...
Regeneron Pharmaceuticals is expanding its cancer drug lineup with FDA approval of a bispecific antibody it developed for multiple myeloma, ...
ADHD stimulant meds don't increase children's risk of psychosis, a new study says. Analysis of stimulant prescriptions among nearly 8,400 ...
A pharmaceutical company that allegedly paid doctors kickbacks to push their HIV/AIDS drugs has agreed to pay a fine of ...
A PepGen drug in development for myotonic dystrophy type 1 (DM1) has encouraging early human data that suggest it could ...
For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 ...
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
GLP-1 drugs currently available for weight loss are administered as once-weekly injections. Verdiva Bio also aims to bring to patients ...
Obesity drugs that offer the benefits of currently available injectable drugs, but in pill form, are part of the next ...
Credit: Unsplash/CC0 Public Domain Would-be dads taking drugs to stop their epilepsy seizures—and valproate in particular—should be largely reassured that ...
First Opinion is STAT’s platform for attention-grabbing, illuminating, and perhaps even provocative articles concerning the life sciences writ massive, written ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.